信达生物授出193.56万份购股权及1024.13万股受限制股份

Group 1 - The company Sinopharm (01801) announced the granting of stock options and restricted shares to a total of 1,374 participants, including directors, under the 2024 share plan [2] - Specifically, 1.9356 million stock options were granted to 66 participants, while 10.2413 million restricted shares were granted to 1,308 participants, pending acceptance by the grantees [2]